TDACU
Translational Development Acquisition Corp.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R May 11 Translational Development Acquisition Corp. (TDACU) filed Amendment…
- X Jul 31 Short interest jumps 200.0% to 3
- X Aug 31 Short interest jumps 100.0% to 6
- X Sep 30 Short interest falls 50.0% to 3
Signal stack
Where each data set points today.
- Short sellersCOVERING
Short interest −50.0% to 3 shares. 1.0 days to cover.
- TrendDOWNTREND
7% below its 50-day average.
Who's buying
13F| Top holder | Shares | Value |
|---|---|---|
| Clear Street Group Inc. | 12,344 | $139.6K |
| UBS Group AG | 8,338 | $94.3K |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Sep 30, 2026SecBot reports
2 filings · 0 bullish · 1 bearish · 1 neutral- NEUTRAL DEFA14AMay 28, 2026
Translational Development Acquisition Corp. (TDACU) filed definitive additional proxy soliciting…
Monitor the shareholder vote outcome on June 17, 2026. Approval of the extension proposals provides the SPAC up to 12 additional months to find a target, reducing near-term liquidation risk. Failure…
- BEARISH 10-K/AMay 11, 2026
Translational Development Acquisition Corp. (TDACU) filed Amendment No. 2 to its 2025 10-K in…
This is a red flag for a pre-deal SPAC — the SEC forced a reversal of the controls opinion, suggesting material deficiencies in financial reporting processes. Monitor for any delay or failure to…
All TDACU filing & press-release reports (2)
- DEFA14A reportMay 28, 2026
- 10-K/A reportMay 11, 2026